Borderline personality disorder

被引:631
|
作者
Leichsenring, Falk [1 ]
Leibing, Eric [2 ]
Kruse, Johannes [1 ]
New, Antonia S. [3 ,4 ]
Leweke, Frank [1 ]
机构
[1] Univ Giessen, Dept Psychosomat & Psychotherapy, D-35392 Giessen, Germany
[2] Univ Goettingen, Dept Psychosomat Med & Psychotherapy, Gottingen, Germany
[3] James J Peters VA Med Ctr, Dept Vet Affairs, Mental Illness Res Educ & Clin Ctr, New York, NY USA
[4] Mt Sinai Sch Med, New York, NY USA
来源
LANCET | 2011年 / 377卷 / 9759期
关键词
DIALECTICAL BEHAVIOR-THERAPY; POSTTRAUMATIC-STRESS-DISORDER; DSM-IV CRITERIA; RANDOMIZED CONTROLLED-TRIAL; TRANSFERENCE-FOCUSED PSYCHOTHERAPY; SEROTONIN TRANSPORTER GENE; CHILDHOOD SEXUAL-ABUSE; DELIBERATE SELF-HARM; DOUBLE-BLIND; FOLLOW-UP;
D O I
10.1016/S0140-6736(10)61422-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent research findings have contributed to an improved understanding and treatment of borderline personality disorder. This disorder is characterised by severe functional impairments, a high risk of suicide, a negative effect on the course of depressive disorders, extensive use of treatment, and high costs to society. The course of this disorder is less stable than expected for personality disorders. The causes are not yet clear, but genetic factors and adverse life events seem to interact to lead to the disorder. Neurobiological research suggests that abnormalities in the frontolimbic networks are associated with many of the symptoms. Data for the effectiveness of pharmacotherapy vary and evidence is not yet robust. Specific forms of psychotherapy seem to be beneficial for at least some of the problems frequently reported in patients with borderline personality disorder. At present, there is no evidence to suggest that one specific form of psychotherapy is more effective than another. Further research is needed on the diagnosis, neurobiology, and treatment of borderline personality disorder.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 50 条
  • [41] Borderline Personality Disorder in the Courtroom
    Lee, Jin S.
    PSYCHIATRY PSYCHOLOGY AND LAW, 2021, 28 (02) : 206 - 217
  • [42] Psychopharmacology of borderline personality disorder
    Soloff, PH
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 23 (01) : 169 - +
  • [43] Etiology of borderline personality disorder
    Salzman, JP
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11): : 1640 - 1641
  • [44] Clozapine and borderline personality disorder
    Parker, GF
    PSYCHIATRIC SERVICES, 2002, 53 (03) : 348 - 349
  • [45] Schizencephaly and Borderline Personality Disorder
    Forcen, Fernando Espi
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (02) : E44 - E44
  • [46] Bigotry and borderline personality disorder
    Chanen, Andrew M.
    AUSTRALASIAN PSYCHIATRY, 2021, 29 (06) : 579 - 580
  • [47] Aggression in Borderline Personality Disorder
    K. Látalová
    J. Praško
    Psychiatric Quarterly, 2010, 81 : 239 - 251
  • [48] Psychopharmacology of borderline personality disorder
    Raj Y.P.
    Current Psychiatry Reports, 2004, 6 (3) : 225 - 231
  • [49] BORDERLINE PERSONALITY-DISORDER
    BURKLE, FM
    RAE, R
    RICE, MM
    ANNALS OF EMERGENCY MEDICINE, 1985, 14 (10) : 996 - 1001
  • [50] Borderline personality disorder and recovery
    Nesnidal, Vlastimil
    Prasko, Jan
    Vanek, Jakub
    Ociskova, Marie
    Holubova, Michaela
    Kantor, Krystof
    Latalova, Klara
    Minarikova, Kamila
    Hodny, Frantisek
    NEUROENDOCRINOLOGY LETTERS, 2020, 41 (06) : 308 - 317